Most telehealth weight loss platforms are selling the same compounded semaglutide with different logos on the box. A handful are genuinely different. Here is how they actually stack up.
What I Looked At
Finding a doctor-supervised weight loss program that is worth the monthly charge means sorting through a crowded field fast. Prices, pharmacy credentials, physician review speed, shipping reach, and how programs handle the branded-versus-compounded question after the March 2026 regulatory shift all matter. I weighted these factors:
- Cash price per month (real first-month cost, not promotional fine print)
- Pharmacy transparency (named facility, certifications, lot tracking)
- Physician oversight model (review speed, credentials, ongoing monitoring)
- Shipping and access (states covered, delivery time)
- Safety signals (FDA warning letters, LegitScript status, USP-797 compliance)
One honest note worth dropping here: compounded GLP-1 medications are not FDA-approved products. That applies to every compounded option on this list, including the top pick.
The 7 Best Doctor-Supervised Weight Loss Programs
1. HealthRX
The detail that matters most: HealthRX names its compounding pharmacy. Manifest Pharmacy in Greer, South Carolina holds 503A status and meets USP-797 sterility standards, with lot-tracked batches from preparation to delivery. That kind of documentation is still rare among cash-pay telehealth providers. Compounded semaglutide starts at $99 per month and compounded tirzepatide at $149. Overnight delivery is included at no extra charge and reaches every state in the country. A board-certified U.S. physician reviews your health intake within roughly 24 hours, and the pharmacy carries LegitScript certification (certificate 50087439). For context, the clinical trials that producers of these molecules ran showed tirzepatide averaging around 21% body weight reduction at 72 weeks (SURMOUNT-1) and semaglutide around 15% at 68 weeks (STEP 1). HealthRX cites those numbers without claiming its compounded product produces identical results, which is the correct approach. At $99 for semaglutide and $149 for tirzepatide with overnight delivery and a named, credentialed pharmacy, very few platforms offer more accountability at this price.
2. Mochi Health
Mochi stands out because its clinicians are board-certified in obesity medicine, not just general practice. That specialty training shapes how providers here approach dosing and plateaus. Compounded semaglutide runs about $99 per month and tirzepatide around $199, putting it in a comparable price tier to HealthRX on semaglutide but higher on tirzepatide. Monitoring is more hands-on than most cash-pay platforms, with regular check-ins built into the model rather than offered as an upsell.
3. FormBlends
FormBlends occupies a specific niche: published lab documentation. The platform posts per-product purity testing including HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility results, which most GLP-1 telehealth brands do not publish in that detail. Compounded semaglutide runs around $299 and tirzepatide around $349, meaningfully higher than HealthRX’s entry pricing. Shipping reaches 47 states, leaving out three. Physician oversight follows a similar telehealth model, dispensed through an FDA-registered 503A compounding pharmacy. The extra cost buys published analytical data and access to a broader peptide catalog covering recovery, longevity, and cognitive formulations, all under the same clinician model. If you want GLP-1 therapy alongside peptides like BPC-157 or other compounds from one provider, FormBlends is the strongest option here. If GLP-1 price and nationwide access are the deciding factors, HealthRX wins that comparison outright.
4. Hims & Hers
Big platform, significant pivot. After the March 2026 Novo settlement, Hims & Hers moved away from compounded GLP-1 products and toward branded medications. Injectable Wegovy is now listed around $299 per month, oral semaglutide around $249, and Zepbound near $399. With insurance and manufacturer savings cards, some patients get to $0 to $25 monthly. The platform is large, the provider network is established, and the insurance handling is more developed than most. Best fit for someone with good coverage who wants a name-brand product and a familiar interface.
5. Ro Body
Ro’s membership structure front-loads the low number: about $39 for the first month, then $74 to $149 per month after that, with medication billed separately on top. The platform has a dedicated prior-authorization team and accepts insurance for branded medications, which saves real money for patients with qualifying coverage. The total monthly cost can look quite different depending on what your plan covers. Worth running the numbers before assuming the entry price is what you will actually pay.
6. PlushCare
PlushCare is a general telehealth platform that handles weight loss alongside primary care, mental health, and other conditions. Membership runs about $19.99 per month. Branded medications and insurance are both supported, and same-day appointments are available in many cases. The breadth of the platform means your weight loss physician is also positioned to manage related conditions, which can simplify care coordination. Not a specialty weight loss program, but a practical pick for patients who want one provider for multiple needs.
7. Found
Found charges around $99 per month for platform access, with medications billed separately on top. The model layers in coaching alongside the medical prescription component. It is not the cheapest option once medication costs are added, and the coaching quality varies by clinician. Still worth considering if you want structured behavioral support alongside the prescription rather than medication alone.
How to Choose
Price is obvious. Start there, but go one level deeper. Is the pharmacy named and credentialed? Can you see what state it operates in and whether it holds USP-797 status? Does the physician review happen before or after you pay? Does the platform take your insurance, and if so, how developed is that process?
Compounded GLP-1 programs make the most sense for cash-pay patients who want lower monthly costs and do not have insurance that covers branded options. Branded programs like Hims & Hers or Ro make more sense when insurance is in play. Specialty-monitoring programs like Mochi are worth the premium if you want obesity-medicine credentials behind your prescription. And if lab documentation is the thing you care about most, FormBlends publishes the data that most platforms simply do not.
No platform replaces a conversation with your own physician about whether GLP-1 therapy is appropriate for you.
Common Questions
Is compounded semaglutide from platforms like HealthRX or Mochi the same drug as Ozempic or Wegovy?
No. Compounded semaglutide uses the same active molecule but is not FDA-approved and is not manufactured by Novo Nordisk. Quality depends entirely on the compounding pharmacy’s standards. Platforms that name their pharmacy, publish lot tracking, and hold USP-797 certification give you more to evaluate than those that do not.
After the March 2026 Novo settlement, can platforms like HealthRX still legally sell compounded semaglutide?
The regulatory situation shifted significantly after that settlement. Compounding is generally still permitted through legitimate 503A pharmacies for individual patient prescriptions, but the legal ground is narrower than it was in 2024 and 2025. Check directly with any platform about its current compliance posture before enrolling.
Why does Mochi charge more for tirzepatide than HealthRX does, and is the extra cost worth it?
Mochi’s tirzepatide runs around $199 versus HealthRX’s $149. The difference reflects Mochi’s obesity-medicine specialist model, which includes more structured ongoing monitoring. If you want a board-certified obesity medicine clinician managing your dosing adjustments and plateaus rather than a general telehealth physician, that $50 gap has a real clinical rationale behind it.
What should I actually verify before paying a doctor-supervised weight loss platform for the first time?
Three things matter most. First, confirm the compounding pharmacy is named and holds 503A status. Second, check whether physician review happens before or after your first payment clears. Third, look up the pharmacy on LegitScript’s public database. HealthRX’s pharmacy, for example, carries certificate 50087439, which you can verify independently in about two minutes.
Does Found or PlushCare make sense if I already have a primary care doctor managing other conditions?
Found and PlushCare serve different needs here. PlushCare is the better fit if you want one telehealth provider handling weight loss alongside other conditions, since it covers primary care and mental health on the same platform. Found is more useful if structured behavioral coaching alongside a GLP-1 prescription is the specific gap your current care arrangement is missing.
Sources
- SURMOUNT-1 trial (tirzepatide): Jastreboff et al., *New England Journal of Medicine*, 2022
- STEP 1 trial (semaglutide): Wilding et al., *New England Journal of Medicine*, 2021
- Federal rules governing 503A compounding pharmacies and enforcement actions taken in early 2026 (FDA.gov)
- LegitScript pharmacy certification database (LegitScript.com)
- Novo Nordisk compounded semaglutide settlement reporting, March 2026 (Reuters, STAT News)
- USP-797 sterile compounding standards (USP.org)
